Pharmaceutical executives meet with Trump to discuss affordability, accessibility of prescription drugs

President Donald J. Trump met today with executives from the nation’s leading pharmaceutical companies to discuss strategies to increase U.S. production while reforming regulations that contribute to higher costs.Stephen J. Ubl, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), described the session as “a positive, productive meeting.”

Full Story →